Long-term survival after surgical treatment followed by adjuvant systemic therapy for primary duodenal melanoma
Sign Up to like & getrecommendations! Published in 2020 at "Clinical Journal of Gastroenterology"
DOI: 10.1007/s12328-020-01112-9
Abstract: Primary mucosal malignant melanomas of the gastrointestinal tract are rare tumors associated to poor prognosis. Primary duodenal involvement by pigmented lesions is even more uncommon, and only a few reports exist in the literature. We… read more here.
Keywords: duodenal melanoma; systemic therapy; followed adjuvant; adjuvant systemic ... See more keywords
Adjuvant therapy for HER2 positive pT1a-b pN0 breast cancer
Sign Up to like & getrecommendations! Published in 2022 at "Medicine"
DOI: 10.1097/md.0000000000029371
Abstract: Abstract Deciding if patients with small (≤1 cm), node-negative, human epidermal growth factor receptor 2 (HER2) positive breast cancer should receive adjuvant systemic therapy remains a challenge. No randomized clinical trials have examined the efficacy of… read more here.
Keywords: adjuvant systemic; breast cancer; systemic therapy; therapy ... See more keywords
A network meta-analysis of adjuvant systemic therapy in resected pancreatic cancer.
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2019.37.4_suppl.396
Abstract: 396 Background: Multiple randomized controlled trials (RCTs) have established several systemic therapy regimens as adjuvant therapy treatment options for resected pancreatic cancer, including modified FOLFRINOX (mFFX), gemcitabine and capecitabine (GemCap) and S1, mostly based on… read more here.
Keywords: therapy; resected pancreatic; adjuvant systemic; systemic therapy ... See more keywords
Neoadjuvant and Adjuvant Systemic Therapy for Newly Diagnosed Stage II–IV Epithelial Ovary, Fallopian Tube, or Primary Peritoneal Carcinoma: A Practice Guideline
Sign Up to like & getrecommendations! Published in 2022 at "Current Oncology"
DOI: 10.3390/curroncol29010022
Abstract: Background: This study aims to provide guidance for the use of neoadjuvant and adjuvant systemic therapy in women with newly diagnosed stage II–IV epithelial ovary, fallopian tube, or primary peritoneal carcinoma. Methods: EMBASE, MEDLINE, and… read more here.
Keywords: systemic therapy; therapy; stage; neoadjuvant adjuvant ... See more keywords